Skip to ContentSkip to Navigation
Research Department of Genetics
University Medical Center Groningen

Cardiogenetics paper awarded Durrer prize

03 April 2013

Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
K. Y. van Spaendonck-Zwarts et al., Neth Heart J (2012) 20:219–228. (link to full paper)

The above paper by our cardiogenetics team on Dutch founder mutations in the desmin gene -published in 2012 in the Netherlands Heart Journal (link)- has been nominated for the Dirk Durrer Scientific Prize of the Netherlands Society of Cardiology (NVVC). Karin van Spaendonck-Zwarts, Ludolf Boven, Jan Jongbloed and Peter van Tintelen are the authors from the Department of Genetics, UMCG. The winning paper was announced on April 4th 2013 at the biannual NVVC Meeting.



Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac phenotype of all carriers, and the founder effects.


We collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using genealogy and haplotype analysis.


We identified three new index patients carrying the p.S13F mutation and two new families carrying the p.N342D mutation. In total, we summarised the clinical details of 39 p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardiac phenotype of p.S13F carriers is fully penetrant and severe, characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement. Although muscle weakness is a prominent and presenting symptom in p.N342D carriers, their cardiac phenotype is similar to that of p.S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haplotype analysis.


DRM may occur as an apparently isolated cardiological disorder. The cardiac phenotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement.

Last modified:18 December 2023 07.30 a.m.
View this page in: Nederlands

More news

  • 11 December 2023

    Join the 'Language and AI' community

    As a part of the Jantina Tammes School, the 'Language and AI' theme is an interdisciplinary initiative that aims to encourage collaboration among academics, PhD candidates, students, and industry representatives who share a keen interest in the...

  • 13 October 2023

    Moniek Tromp appointed Captain of Science of the Top Sector Chemistry

    Prof. Moniek Tromp has been appointed Captain of Science of the Chemistry Top Sector by the Minister of Economic Affairs and Climate Policy. As from 1 July 2023, she succeeded Prof. Bert Weckhuysen from Utrecht University.

  • 12 September 2023

    Art in times of AI

    Leonardo Arriagada Beltran conducted his PhD research on the interface of computer-generated art and the constantly evolving field of Artificial Intelligence (AI). He will defend his Phd thesis on 21 September. His research offers valuable insights...